dc.contributor.author |
Ziemann, Ulf |
|
dc.date.accessioned |
2017-03-21T15:55:15Z |
|
dc.date.available |
2017-03-21T15:55:15Z |
|
dc.date.issued |
2016 |
|
dc.identifier.issn |
1557-1904 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/75250 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Springer |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1007/s11481-015-9646-5 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID) |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20160915142648_01578 |
|
utue.publikation.seiten |
1-8 |
de_DE |
utue.personen.roh |
Rommer, P. S. |
|
utue.personen.roh |
Doerner, T. |
|
utue.personen.roh |
Freivogel, K. |
|
utue.personen.roh |
Haas, J. |
|
utue.personen.roh |
Kieseier, B. C. |
|
utue.personen.roh |
Kuempfel, T. |
|
utue.personen.roh |
Paul, F. |
|
utue.personen.roh |
Proft, F. |
|
utue.personen.roh |
Schulze-Koops, H. |
|
utue.personen.roh |
Schmidt, E. |
|
utue.personen.roh |
Wiendl, H. |
|
utue.personen.roh |
Ziemann, U. |
|
utue.personen.roh |
Zettl, U. K. |
|
dcterms.isPartOf.ZSTitelID |
Journal of Neuroimmune Pharmacology |
de_DE |
dcterms.isPartOf.ZS-Issue |
1 |
de_DE |
dcterms.isPartOf.ZS-Volume |
11 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |